Advancing Cancer Diagnostics with Mark McDonough, CEO of Chromacode episode artwork

EPISODE · Feb 26, 2024 · 20 MIN

Advancing Cancer Diagnostics with Mark McDonough, CEO of Chromacode

from From Lab to Launch by Qualio · host Qualio & ChromaCode

In this episode we interview Mark McDonough, the CEO of ChromaCode. The episode explores McDonough's journey to ChromaCode, from his early career as a naval officer to his roles at various medical and diagnostic companies. Under McDonough's leadership, ChromaCode has excelled in creating a high-definition PCR platform which enables fast, accurate, and affordable cancer diagnosis. The platform is particularly beneficial as it requires less patient tissue, provides rapid results, and has a lower cost than traditional diagnostic methods. McDonough also discusses the importance of partnerships in their go-to-market strategy and shared his insights on hiring and team development in today's competitive market. Looking ahead, ChromaCode expects to become a leader in developing innovative products for disease diagnosis, with a focus on patient-centered outcomes.https://www.chromacode.com/ https://www.linkedin.com/in/mark-mcdonough-b1055216/ 00:00 Introduction to the Podcast00:40 Meet the Guest: Mark McDonough, CEO of ChromaCode01:47 Mark's Journey to ChromaCode06:05 Insights on Leadership and Building High Performing Teams08:10 ChromaCode's Innovative Approach to PCR Testing10:36 ChromaCode's Contribution to Precision Medicine13:50 The Importance of Partnerships in ChromaCode's Strategy16:33 Future Prospects for ChromaCode18:27 Getting to Know Mark: Personal Interests19:13 Closing Remarks and Contact InformationAbout Mark McDonoughMark has over 25 years of experience helping build high growth HealthCare organizations. He is passionate about his team, his customers, and the patients that he and they are privileged to help serve. He most recently was the CEO of Pierian (now Velsera) which he led to a successful sale to Summa Equity, a private equity firm, in 2022. Prior to Pierian, he led CombiMatrix for five years, culminating in a sale to Invitae in 2017. Over his career, Mark has held various executive and commercial positions, and served as a US Naval Officer.Qualio website:https://www.qualio.com/Previous episodes:https://www.qualio.com/from-lab-to-launch-podcastApply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8Music by keldez

Episode metadata supplied by the publisher feed · Published Feb 26, 2024

Embed this episode

In this episode we interview Mark McDonough, the CEO of ChromaCode. The episode explores McDonough's journey to ChromaCode, from his early career as a naval officer to his roles at various medical and diagnostic companies. Under McDonough's leadership, ChromaCode has excelled in creating a high-definition PCR platform which enables fast, accurate, and affordable cancer diagnosis. The platform is particularly beneficial as it requires less patient tissue, provides rapid results, and has a lowe...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Advancing Cancer Diagnostics with Mark McDonough, CEO of Chromacode

0:00 20:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of From Lab to Launch by Qualio?

This episode is 20 minutes long.

When was this From Lab to Launch by Qualio episode published?

This episode was published on February 26, 2024.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this From Lab to Launch by Qualio episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!